Glenn Saldanha Chairman & Managing Director of Glenmark Pharmaceuticals Ltd., joined in 1998 as Director and took over as Managing Director & CEO in 2001.
As Chairman & Managing Director of the Company, Mr. Saldanha oversees all operations of the organization. During his tenure, he transformed Glenmark into a truly global organization with revenue over a billion dollar and commercial presence in over 80 countries. Under his leadership, Glenmark has evolved from an Indian branded generics business, into a research-driven and innovation-led organization. Mr. Saldanha’s vision is to discover, develop and take to market India’s first innovative drug for the entire world.
Mr. Saldanha holds a bachelor’s degree in pharmacy from Mumbai University and is an MBA from the Leonard Stern School of Business at New York University. Prior to Glenmark, he has worked with Eli Lily, USA and PriceWater House Coopers, USA.
Investors include Singapore’s Temasek.
Real Time Net Worth $1.8 B.
Source: FORBES // Glenmark Pharmaceuticals Ltd.